• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口咽型初乳免疫疗法和极低出生体重早产儿死亡率降低的关系:一项临床试验。

Oropharyngeal colostrum immunotherapy and risk reduction of mortality in very low birth weight premature newborns: a clinical trial.

机构信息

Universidade Estadual de Feira de Santana, Departamento de Saúde, Feira de Santana, BA, Brazil.

Universidade Federal do Recôncavo da Bahia, Centro de Ciências da Saúde, Santo Antônio de Jesus, BA, Brazil.

出版信息

J Pediatr (Rio J). 2024 Jan-Feb;100(1):32-39. doi: 10.1016/j.jped.2023.07.007. Epub 2023 Sep 7.

DOI:10.1016/j.jped.2023.07.007
PMID:37690464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10751697/
Abstract

OBJECTIVE

To evaluate the effect of oropharyngeal colostrum immunotherapy (OCI) on the mortality of preterm newborns (PTNB) with very low birth weight (VLBW).

METHOD

Non-randomized clinical trial, carried out with 138 mother-child pairs attended at a public maternity hospital. The treatment group used raw colostrum, dripping 4 drops (0.2 ml) into the oropharyngeal mucosa, totaling 8 administrations in 24 h, up to the 7th complete day of life (OCI). The control group was composed of newborns admitted to the same maternity hospital before the implementation of the OCI. Analyzes were performed: descriptive, bivariate, multiple logistic regression, and survival analysis, with a significance level of 5% and 95% CI.

RESULTS

The treatment group had an RR of death of 0.26 (95% CI = 0.07-0.67; p = 0.00), adjusted for maternal age, marital status, gestational hypertension, type of delivery, number of prenatal visits, and birth weight. Number Needed to Treat (NNT) demonstrated that for every 5 individuals treated with OCI, one death was prevented NNT = 4.9 (95% CI = 1.84-5.20); however, for PTNB with VLBW who remained hospitalized for 50, 100 and 150 days, the NNT reduces to 4, 4 and 3, respectively.

CONCLUSION

The OCI proved to be a beneficial intervention, since it reduced the risk of mortality in PTNB with VLBW when compared to the control group.

摘要

目的

评估口咽乳免疫疗法(OCI)对极低出生体重早产儿(PTNB)死亡率的影响。

方法

非随机临床试验,纳入了在一家公立医院就诊的 138 对母婴。治疗组使用生乳,每次 4 滴(0.2 毫升)滴入口腔黏膜,24 小时内共 8 次,直至第 7 个完整的生命日(OCI)。对照组由在 OCI 实施前入住同一家妇产医院的新生儿组成。分析方法:描述性、双变量、多变量逻辑回归和生存分析,显著性水平为 5%和 95%置信区间。

结果

治疗组的死亡风险比为 0.26(95%置信区间=0.07-0.67;p=0.00),调整了母亲年龄、婚姻状况、妊娠高血压、分娩方式、产前检查次数和出生体重。需要治疗的人数(NNT)表明,每治疗 5 例 OCI,就可预防 1 例死亡,NNT=4.9(95%置信区间=1.84-5.20);然而,对于在医院住院 50、100 和 150 天的 VLBW 极低出生体重 PTNB,NNT 分别降至 4、4 和 3。

结论

OCI 被证明是一种有益的干预措施,因为与对照组相比,它降低了极低出生体重早产儿(PTNB)的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e809/10751697/e82cb4b7f27f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e809/10751697/5c2521742676/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e809/10751697/e82cb4b7f27f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e809/10751697/5c2521742676/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e809/10751697/e82cb4b7f27f/gr2.jpg

相似文献

1
Oropharyngeal colostrum immunotherapy and risk reduction of mortality in very low birth weight premature newborns: a clinical trial.口咽型初乳免疫疗法和极低出生体重早产儿死亡率降低的关系:一项临床试验。
J Pediatr (Rio J). 2024 Jan-Feb;100(1):32-39. doi: 10.1016/j.jped.2023.07.007. Epub 2023 Sep 7.
2
Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: protocol of an intervention study.初乳经口咽免疫疗法用于极低出生体重早产儿:一项干预性研究方案
BMC Pediatr. 2020 Aug 7;20(1):371. doi: 10.1186/s12887-020-02266-8.
3
Oropharyngeal colostrum immunotherapy and nutrition in preterm newborns: meta-analysis.口腔胎粪免疫治疗和营养在早产儿中的应用:荟萃分析。
Rev Saude Publica. 2021 Dec 17;55:59. doi: 10.11606/s1518-8787.2021055003051. eCollection 2021.
4
Analysis of clinical outcomes of oropharyngeal colostrum administration in very low-birth-weight preterm newborns.分析经口给予早产儿母乳对极低出生体重儿的临床结局的影响。
Nutrition. 2021 Oct;90:111292. doi: 10.1016/j.nut.2021.111292. Epub 2021 Apr 28.
5
The effect of oropharyngeal colostrum administration on the clinical outcomes of premature infants: A meta-analysis.口咽给予初乳对早产儿临床结局的影响:一项荟萃分析。
Int J Nurs Stud. 2023 Aug;144:104527. doi: 10.1016/j.ijnurstu.2023.104527. Epub 2023 May 19.
6
The Effects of Early Oropharyngeal Administration of Microdosed Colostrum on Feeding Status in Ventilated Extremely Low-Birth-Weight Infants.微量牛初乳早期口腔给药对机械通气极低出生体重儿喂养状况的影响。
Breastfeed Med. 2021 Aug;16(8):648-653. doi: 10.1089/bfm.2020.0244. Epub 2021 May 13.
7
Oropharyngeal colostrum therapy reduces the incidence of ventilator-associated pneumonia in very low birth weight infants: a systematic review and meta-analysis.口咽初乳疗法降低极低出生体重儿呼吸机相关性肺炎的发生率:一项系统评价和荟萃分析。
Pediatr Res. 2021 Jan;89(1):54-62. doi: 10.1038/s41390-020-0854-1. Epub 2020 Mar 30.
8
Randomized Controlled Trial of Oropharyngeal Colostrum Administration in Very-low-birth-weight Preterm Infants.随机对照试验:口腔给予初乳对极低出生体重早产儿的影响。
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):126-130. doi: 10.1097/MPG.0000000000002356.
9
Oropharyngeal Colostrum Administration in Very Low Birth Weight Infants: A Randomized Controlled Trial.极低出生体重儿口咽给予初乳:一项随机对照试验
Pediatr Crit Care Med. 2017 Sep;18(9):869-875. doi: 10.1097/PCC.0000000000001221.
10
Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized controlled trial.经口给予初乳预防胎龄 ≤ 32 周早产儿坏死性小肠结肠炎和晚发性败血症的单中心随机对照试验。
Int Breastfeed J. 2021 Aug 21;16(1):59. doi: 10.1186/s13006-021-00408-x.